|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Net amortization of premiums and discounts on investment securities | |||||
| Provision for credit losses | |||||
| Credit for deferred income taxes | |||||
| Change in fair value of marketable equity securities | |||||
| Depreciation and amortization | |||||
| Amortization of debt issuance costs | |||||
| Increase in cash surrender value of bank-owned life insurance | |||||
| Gains and fees from sales of loans | |||||
| Stock-based compensation | |||||
| Loss on sale of premises and equipment | |||||
| Loss on sale of other real estate owned | |||||
| Change in other real estate owned | |||||
| Net change in: | |||||
| Deferred tax assets | |||||
| Deferred loan fees | |||||
| Accrued interest receivable | |||||
| Other assets | |||||
| Accrued expenses and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Proceeds from principal repayments on available for sale securities | |||||
| Proceeds from principal repayments on held to maturity securities | |||||
| Net proceeds from sales and calls of available for sale securities | |||||
| Net proceeds from sales and calls of held to maturity securities | |||||
| Purchases of available for sale securities | |||||
| Purchases of marketable equity securities | |||||
| Purchases of held to maturity securities | |||||
| Net increase in loans | |||||
| Proceeds from sales of loans not originated for sale | |||||
| Purchases of premises and equipment, net | |||||
| Proceeds (purchases) of Federal Home Loan Bank stock | |||||
| Proceeds from the sale of other real estate owned | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Net change in time certificates of deposit | |||||
| Net change in other deposits | |||||
| Net change in FHLB advances | |||||
| Proceeds from exercise of options | |||||
| Issuance of subordinated debt | |||||
| Payments on FHLB advances | |||||
| Proceeds on FHLB advances | |||||
| Dividends paid on common stock | |||||
| Repurchase of common stock | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents: | |||||
| Beginning of year | |||||
| End of period | |||||
| Supplemental disclosures of cash flows information: | |||||
| Cash paid for: | |||||
| Interest | |||||
| Income taxes: | |||||
| Income taxes: | |||||
| Federal | |||||
| State: | |||||
| New York City | |||||
| New York State | |||||
| Florida | |||||
| New Jersey | |||||
| Other | |||||
| Noncash investing and financing activities | |||||
| Loans transferred to other real estate owned | |||||
| Premises and equipment transferred to held for sale | |||||
| Net change in unrealized losses or gains on available-for-sale securities | |||||
| Net change in unrealized losses or gains on interest rate swaps | |||||
| Establishment of right-of-use-asset and lease liability | |||||
| Transfer of loans from held-for-investment to held-for-sale | |||||
Loading...